/ Print /

Health/Disease Strategy

Patient experience with immunotherapy: 4 things health execs need to knowCAR T-cell therapies and other immunotherapy give this oncologist’s cancer patients hope for a better quality of life.
Why MS relapse rates are underreported: What health execs should knowTwo patient survey studies sponsored by Mallinckrodt reveal findings about patient-reported multiple sclerosis rates.
Two asthma treatment recommendations for health organizationsAllergist Bradley Chipps, MD, shares research on how to fine-tune asthma management strategies.
Landmark study identifies asthma in infantsA Canadian study reveals how clinicians may be able to identify whether asthma will develop in patients as young as age one.
Four oncology treatment advances to watch
Four oncology treatment advances to watchExperts say a cancer care revolution is here. Here’s a closer look at some advancements in cancer treatments to watch.
Genetic testing: 3 things managed healthcare executives should knowA new survey on genetic testing has surprisingly results on consumer acceptance and impact for healthcare executives.
Here’s a more effective way to test for HPVA Kaiser Permanente study found that a new way to test for HPV has the potential to increase efficiency and decrease waste.
‘Encouraging’ COPD drug pipeline could ease symptoms, address root causesAlbert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow address the underlying disease process.
Don’t let your tools to curb the opioid epidemic go to wasteNew public opinion survey about opioid use from Prime Therapeutics has surprising results.
Unique payer-provider cancer treatment partnershipsUnique partnerships between payers and providers focus on keeping patients out of the hospital and on the road to remission.